Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
04 2019
Historique:
received: 22 05 2018
revised: 04 01 2019
accepted: 07 01 2019
entrez: 3 4 2019
pubmed: 3 4 2019
medline: 12 2 2020
Statut: ppublish

Résumé

Radiation pneumonitis (RP) is a radiotherapy dose-limiting toxicity for locally advanced non-small cell lung cancer (LA-NSCLC). Prior studies have proposed relevant dosimetric constraints to limit this toxicity. Using machine learning algorithms, we performed analyses of contributing factors in the development of RP to uncover previously unidentified criteria and elucidate the relative importance of individual factors. We evaluated 32 clinical features per patient in a cohort of 203 stage II-III LA-NSCLC patients treated with definitive chemoradiation to a median dose of 66.6 Gy in 1.8 Gy daily fractions at our institution from 2008 to 2016. Of this cohort, 17.7% of patients developed grade ≥2 RP. Univariate analysis was performed using trained decision stumps to individually analyze statistically significant predictors of RP and perform feature selection. Applying Random Forest, we performed multivariate analysis to assess the combined performance of important predictors of RP. On univariate analysis, lung V20, lung mean, lung V10 and lung V5 were found to be significant RP predictors with the greatest balance of specificity and sensitivity. On multivariate analysis, Random Forest (AUC = 0.66, p = 0.0005) identified esophagus max (20.5%), lung V20 (16.4%), lung mean (15.7%) and pack-year (14.9%) as the most common primary differentiators of RP. We highlight Random Forest as an accurate machine learning method to identify known and new predictors of symptomatic RP. Furthermore, this analysis confirms the importance of lung V20, lung mean and pack-year as predictors of RP while also introducing esophagus max as an important RP predictor.

Sections du résumé

BACKGROUND AND PURPOSE
Radiation pneumonitis (RP) is a radiotherapy dose-limiting toxicity for locally advanced non-small cell lung cancer (LA-NSCLC). Prior studies have proposed relevant dosimetric constraints to limit this toxicity. Using machine learning algorithms, we performed analyses of contributing factors in the development of RP to uncover previously unidentified criteria and elucidate the relative importance of individual factors.
MATERIALS AND METHODS
We evaluated 32 clinical features per patient in a cohort of 203 stage II-III LA-NSCLC patients treated with definitive chemoradiation to a median dose of 66.6 Gy in 1.8 Gy daily fractions at our institution from 2008 to 2016. Of this cohort, 17.7% of patients developed grade ≥2 RP. Univariate analysis was performed using trained decision stumps to individually analyze statistically significant predictors of RP and perform feature selection. Applying Random Forest, we performed multivariate analysis to assess the combined performance of important predictors of RP.
RESULTS
On univariate analysis, lung V20, lung mean, lung V10 and lung V5 were found to be significant RP predictors with the greatest balance of specificity and sensitivity. On multivariate analysis, Random Forest (AUC = 0.66, p = 0.0005) identified esophagus max (20.5%), lung V20 (16.4%), lung mean (15.7%) and pack-year (14.9%) as the most common primary differentiators of RP.
CONCLUSIONS
We highlight Random Forest as an accurate machine learning method to identify known and new predictors of symptomatic RP. Furthermore, this analysis confirms the importance of lung V20, lung mean and pack-year as predictors of RP while also introducing esophagus max as an important RP predictor.

Identifiants

pubmed: 30935565
pii: S0167-8140(19)30007-6
doi: 10.1016/j.radonc.2019.01.003
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-112

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

José Marcio Luna (JM)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States. Electronic address: Jose.Luna@uphs.upenn.edu.

Hann-Hsiang Chao (HH)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.

Eric S Diffenderfer (ES)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.

Gilmer Valdes (G)

Department of Radiation Oncology, University of California San Francisco, United States.

Chidambaram Chinniah (C)

Albany Medical College, United States.

Grace Ma (G)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.

Keith A Cengel (KA)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.

Timothy D Solberg (TD)

Department of Radiation Oncology, University of California San Francisco, United States.

Abigail T Berman (AT)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States.

Charles B Simone (CB)

Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH